Percutaneous Computed Tomography-Guided Cryoablation as a Treatment Option in Patients with Small Renal Masses: A 10 Year Experience in a Single Center
Background: To evaluate p-Cry in 10 years as a feasible and radical approach in patients with small renal masses (<5 cm), we evaluated technical success, side effects, and survival rates. Materials and Methods: We retrospectively evaluated 421 patients with small renal masses (<5 cm) with a me...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Radiation |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2673-592X/4/4/26 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850085178071842816 |
|---|---|
| author | Luca Marinelli Sara Mercogliano Oscar Selvaggio Giuseppe Carrieri Raffaele Sorrentino Paola Mangano Gianluca Prencipe Luca Macarini Grazia Casavecchia Matteo Gravina |
| author_facet | Luca Marinelli Sara Mercogliano Oscar Selvaggio Giuseppe Carrieri Raffaele Sorrentino Paola Mangano Gianluca Prencipe Luca Macarini Grazia Casavecchia Matteo Gravina |
| author_sort | Luca Marinelli |
| collection | DOAJ |
| description | Background: To evaluate p-Cry in 10 years as a feasible and radical approach in patients with small renal masses (<5 cm), we evaluated technical success, side effects, and survival rates. Materials and Methods: We retrospectively evaluated 421 patients with small renal masses (<5 cm) with a median age of 70 years (47–92 C.I.) between June 2014 and July 2024 at our department. We also evaluated side effects, surgical radicality, and therapeutic outcomes of renal functions. Survivals were also evaluated in terms of disease-free, metastasis-free, and cancer-related survival rates. Results: Median follow-up was 90 months (1–120 months C.I.), and median size of the tumor was 3.85 cm (1–4 C.I.). Two cryoprobes were used in median, and two 10-min freeze–thaw cycles were performed. The technical efficacy rate was 100%, whereas only one of 121 lesions required retreatment. No impact on the renal function was registered after p-Cry. Cancer-free survival and metastases-free survival was reached. Conclusions: Compared to surgery, p-Cry is a feasible treatment option in patients with small renal masses, as it does not affect renal function and gives patients good survival rates. |
| format | Article |
| id | doaj-art-e6916a31b01d4d17b34eb4c67e319b51 |
| institution | DOAJ |
| issn | 2673-592X |
| language | English |
| publishDate | 2024-11-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Radiation |
| spelling | doaj-art-e6916a31b01d4d17b34eb4c67e319b512025-08-20T02:43:47ZengMDPI AGRadiation2673-592X2024-11-014434635410.3390/radiation4040026Percutaneous Computed Tomography-Guided Cryoablation as a Treatment Option in Patients with Small Renal Masses: A 10 Year Experience in a Single CenterLuca Marinelli0Sara Mercogliano1Oscar Selvaggio2Giuseppe Carrieri3Raffaele Sorrentino4Paola Mangano5Gianluca Prencipe6Luca Macarini7Grazia Casavecchia8Matteo Gravina9Department of Radiology, University of Foggia, 71122 Foggia, ItalyAzienda Ospedaliera di Rilievo Nazionale (A.O.R.N.) Santi Anna e Sebastiano, 81100 Caserta, ItalyDepartment of Urology, University of Foggia, 71122 Foggia, ItalyDepartment of Urology, University of Foggia, 71122 Foggia, ItalyDepartment of Radiology, University of Foggia, 71122 Foggia, ItalyDepartment of Radiology, University of Foggia, 71122 Foggia, ItalyDepartment of Radiology, University of Foggia, 71122 Foggia, ItalyDepartment of Radiology, University of Foggia, 71122 Foggia, ItalyDepartment of Cardiology, University of Foggia, 71122 Foggia, ItalyDepartment of Radiology, University of Foggia, 71122 Foggia, ItalyBackground: To evaluate p-Cry in 10 years as a feasible and radical approach in patients with small renal masses (<5 cm), we evaluated technical success, side effects, and survival rates. Materials and Methods: We retrospectively evaluated 421 patients with small renal masses (<5 cm) with a median age of 70 years (47–92 C.I.) between June 2014 and July 2024 at our department. We also evaluated side effects, surgical radicality, and therapeutic outcomes of renal functions. Survivals were also evaluated in terms of disease-free, metastasis-free, and cancer-related survival rates. Results: Median follow-up was 90 months (1–120 months C.I.), and median size of the tumor was 3.85 cm (1–4 C.I.). Two cryoprobes were used in median, and two 10-min freeze–thaw cycles were performed. The technical efficacy rate was 100%, whereas only one of 121 lesions required retreatment. No impact on the renal function was registered after p-Cry. Cancer-free survival and metastases-free survival was reached. Conclusions: Compared to surgery, p-Cry is a feasible treatment option in patients with small renal masses, as it does not affect renal function and gives patients good survival rates.https://www.mdpi.com/2673-592X/4/4/26interventional radiologyrenal cancercryo ablation |
| spellingShingle | Luca Marinelli Sara Mercogliano Oscar Selvaggio Giuseppe Carrieri Raffaele Sorrentino Paola Mangano Gianluca Prencipe Luca Macarini Grazia Casavecchia Matteo Gravina Percutaneous Computed Tomography-Guided Cryoablation as a Treatment Option in Patients with Small Renal Masses: A 10 Year Experience in a Single Center Radiation interventional radiology renal cancer cryo ablation |
| title | Percutaneous Computed Tomography-Guided Cryoablation as a Treatment Option in Patients with Small Renal Masses: A 10 Year Experience in a Single Center |
| title_full | Percutaneous Computed Tomography-Guided Cryoablation as a Treatment Option in Patients with Small Renal Masses: A 10 Year Experience in a Single Center |
| title_fullStr | Percutaneous Computed Tomography-Guided Cryoablation as a Treatment Option in Patients with Small Renal Masses: A 10 Year Experience in a Single Center |
| title_full_unstemmed | Percutaneous Computed Tomography-Guided Cryoablation as a Treatment Option in Patients with Small Renal Masses: A 10 Year Experience in a Single Center |
| title_short | Percutaneous Computed Tomography-Guided Cryoablation as a Treatment Option in Patients with Small Renal Masses: A 10 Year Experience in a Single Center |
| title_sort | percutaneous computed tomography guided cryoablation as a treatment option in patients with small renal masses a 10 year experience in a single center |
| topic | interventional radiology renal cancer cryo ablation |
| url | https://www.mdpi.com/2673-592X/4/4/26 |
| work_keys_str_mv | AT lucamarinelli percutaneouscomputedtomographyguidedcryoablationasatreatmentoptioninpatientswithsmallrenalmassesa10yearexperienceinasinglecenter AT saramercogliano percutaneouscomputedtomographyguidedcryoablationasatreatmentoptioninpatientswithsmallrenalmassesa10yearexperienceinasinglecenter AT oscarselvaggio percutaneouscomputedtomographyguidedcryoablationasatreatmentoptioninpatientswithsmallrenalmassesa10yearexperienceinasinglecenter AT giuseppecarrieri percutaneouscomputedtomographyguidedcryoablationasatreatmentoptioninpatientswithsmallrenalmassesa10yearexperienceinasinglecenter AT raffaelesorrentino percutaneouscomputedtomographyguidedcryoablationasatreatmentoptioninpatientswithsmallrenalmassesa10yearexperienceinasinglecenter AT paolamangano percutaneouscomputedtomographyguidedcryoablationasatreatmentoptioninpatientswithsmallrenalmassesa10yearexperienceinasinglecenter AT gianlucaprencipe percutaneouscomputedtomographyguidedcryoablationasatreatmentoptioninpatientswithsmallrenalmassesa10yearexperienceinasinglecenter AT lucamacarini percutaneouscomputedtomographyguidedcryoablationasatreatmentoptioninpatientswithsmallrenalmassesa10yearexperienceinasinglecenter AT graziacasavecchia percutaneouscomputedtomographyguidedcryoablationasatreatmentoptioninpatientswithsmallrenalmassesa10yearexperienceinasinglecenter AT matteogravina percutaneouscomputedtomographyguidedcryoablationasatreatmentoptioninpatientswithsmallrenalmassesa10yearexperienceinasinglecenter |